TAIPEI, 9 Ocak, 2024 /PRNewswire/ — Infortrend® Technology, Inc. (TWSE: 2495), sektörün önde gelen kuruluşlara yönelik depolama alanı sağlayıcısıdır ve veri tabanı, web sunucusu ve mail sunucusu gibi kuruluş uygulamalarının yüksek kullanılabilirliğini sağlayarak HA (Yüksek Kullanılabilirlik) Hizmeti ile işlerin devamlılığını destekler. Bu çözüm, iş açısından kritik uygulamaların sürekli olarak devam ettirilmesi için kolay ve uygun maliyetli… Continue reading Infortrend’in HA Hizmeti İş Açısından Kritik Uygulamaların Kusursuz Çalışması için Yüksek Kullanılabilirlik Sağlıyor
Category: Newswire
New Project Media Acquires Energy Rev, Announces Expansion into Europe
NPM’s growth and reach broadens with strategic acquisition of leading proprietary news service covering European renewables & the energy transition PRINCETON, N.J., Jan. 9, 2024 /PRNewswire/ — New Project Media (NPM), a rapidly growing renewable energy market data, intelligence, and events company, announced today its acquisition of Energy Rev, a London-based proprietary news service focused… Continue reading New Project Media Acquires Energy Rev, Announces Expansion into Europe
UPL To Strengthen Fungicide Portfolio with Planned Acquisition of Corteva’s Mancozeb Business
UPL to acquire Corteva Agriscience’s global mancozeb fungicide business outside of China, Japan, South Korea and EU member countries Mancozeb is a highly effective protective fungicide used to prevent plant diseases across a range of crops LONDON, Jan. 9, 2024 /PRNewswire/ — UPL Ltd. (NSE: UPL & BSE: 512070 LSE: UPLL) (‘UPL’), the global provider… Continue reading UPL To Strengthen Fungicide Portfolio with Planned Acquisition of Corteva’s Mancozeb Business
AbbVie Launches PRODUODOPA® (foslevodopa/foscarbidopa) for People Living with Advanced Parkinson’s Disease in the European Union
– PRODUODOPA® (foslevodopa/foscarbidopa) is the first-and-only subcutaneous 24-hour infusion of levodopa-based therapy for the treatment of advanced Parkinson’s disease – PRODUODOPA demonstrated sustained improvements in “Off” time (when symptoms return between medication doses), “On” time (when symptoms are controlled) without dyskinesia (involuntary movement), and morning akinesia (“Off” time upon waking) NORTH CHICAGO, Ill.,… Continue reading AbbVie Launches PRODUODOPA® (foslevodopa/foscarbidopa) for People Living with Advanced Parkinson’s Disease in the European Union
ASE Technology Holding Co., Ltd. Announces Monthly Net Revenues*
TAIPEI, Jan. 9, 2024 /PRNewswire/ — ASE Technology Holding Co., Ltd. (NYSE: ASX, TAIEX: 3711, “ASEH” or the “Company”), announces its revised unaudited consolidated net revenues for December, 4th quarter and full year of 2023. CONSOLIDATED NET REVENUES (UNAUDITED) Dec Nov Dec Sequential YoY (NT$ Million) 2023 2023 2022 Change Change Net Revenues 49,906 54,509 53,139… Continue reading ASE Technology Holding Co., Ltd. Announces Monthly Net Revenues*
New Project Media Acquires Energy Rev, Announces Expansion into Europe
NPM’s growth and reach broadens with strategic acquisition of leading proprietary news service covering European renewables & the energy transition PRINCETON, N.J., Jan. 9, 2024 /PRNewswire/ — New Project Media (NPM), a rapidly growing renewable energy market data, intelligence, and events company, announced today its acquisition of Energy Rev, a London-based proprietary news service focused… Continue reading New Project Media Acquires Energy Rev, Announces Expansion into Europe
All-Terrain Vehicle (ATV) Transmission System Market size to grow by USD 174.5 million from 2023 to 2028; market is concentrated due to the presence of prominent companies like Bombardier Recreational Products Inc., Gibbs Amphibians Ltd. and Hilliard Corp., many more
NEW YORK, Jan. 9, 2024 /PRNewswire/ — The all-terrain vehicle (ATV) transmission system market is estimated to grow by USD 174.5 million from 2023 to 2028, growing at a CAGR of 4.37%. The all-terrain vehicle (ATV) transmission system market is concentrated owing to the presence of many global and regional companies. A few prominent companies that… Continue reading All-Terrain Vehicle (ATV) Transmission System Market size to grow by USD 174.5 million from 2023 to 2028; market is concentrated due to the presence of prominent companies like Bombardier Recreational Products Inc., Gibbs Amphibians Ltd. and Hilliard Corp., many more
DeepRoute.ai Partners with Tencent Map; Unveils Collaboration for 2024 Smart Driving Cars Release
Proven solution maturity and commercialization success of OEM use case FREMONT, Calif., Jan. 9, 2024 /PRNewswire/ — DeepRoute.ai, the smart driving solution provider, has recently announced collaboration with Tencent in the field of map. The joint solutions will be integrated in consumer vehicles set to debut in 2024, encompassing a range of car models such as… Continue reading DeepRoute.ai Partners with Tencent Map; Unveils Collaboration for 2024 Smart Driving Cars Release
ForexVox Rebrands to MarketsVox: A Landmark Evolution Reflecting Growth and Innovation
LONDON, Jan. 9, 2024 /PRNewswire/ — ForexVox, a prominent name in the online trading sphere, proudly announces a significant transformation with its rebranding to MarketsVox. This momentous shift goes beyond a mere change in name; it symbolizes a strategic and forward-thinking approach that encapsulates the company’s vision for the future. Continue Reading ForexVox becomes MarketsVox… Continue reading ForexVox Rebrands to MarketsVox: A Landmark Evolution Reflecting Growth and Innovation
Chiesi Group and Oak Hill Bio announce License and Development Agreement to develop, manufacture, and commercialise OHB-607, a potentially transformative neonatal therapy
Chiesi Group and Oak Hill Bio will collaborate closely to develop OHB-607, a clinical-stage investigational drug candidate, to treat complications of extremely premature birth; This agreement expands Chiesi’s commitment to Neonatology, a highly strategic area for the company; Partners intend to restart Phase 2b clinical trial of OHB-607 in 2024. PARMA, Italy and CAMBRIDGE, Mass.,… Continue reading Chiesi Group and Oak Hill Bio announce License and Development Agreement to develop, manufacture, and commercialise OHB-607, a potentially transformative neonatal therapy